Skip to main content
. 2021 Feb 10;26(5):366–374. doi: 10.1002/onco.13697

Figure 3.

Figure 3

(A): Predicted means and 95% confidence intervals for the TNSc (higher scores indicate greater neuopathy severity) and patient‐reported neuropathy burden (FACT/GOG‐Ntx score; lower scores indicate greater neuropathy burden). Assessments collected during treatment (weeks) and at postcompletion (months). (B): Predicted means and 95% confidence intervals for von Frey monofilaments (mN) preformed in the upper limb and two‐point discrimination (mm) preformed in the lower limb. Great values indicating greater deficits. Assessments collected during treatment (weeks) and at postcompletion (months). Abbreviations: FACT/GOG‐Ntx, Functional Assessment of Cancer Therapy/Gynecologic Oncology Group‐Neurotoxicity; TNSc, Total Neuropathy Score clinical version.